We are live on ! Find out more
TPA

Trivium Point Advisory Portfolio holdings

AUM $553M
1-Year Est. Return 26.47%
This Fund
S&P 500
This Quarter Est. Return
+11.69%
1 Year Est. Return
+26.47%
3 Year Est. Return
+86.73%
5 Year Est. Return
+93.38%
10 Year Est. Return
AUM
$465M
AUM Growth
+$52.3M
Cap. Flow
+$15.3M
Cap. Flow %
3.3%
Top 10 Hldgs %
28.14%
Holding
234
New
33
Increased
95
Reduced
71
Closed
15

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$3.09M
2
GILD icon
Gilead Sciences
GILD
+$2.01M
3
ACN icon
Accenture
ACN
+$1.55M
4
ARCC icon
Ares Capital
ARCC
+$1.2M
5
EMR icon
Emerson Electric
EMR
+$1.14M

Sector Composition

Rank Sector Weight
1 Technology 18.51%
2 Financials 12.05%
3 Communication Services 11.18%
4 Consumer Discretionary 8.69%
5 Healthcare 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
51
Vertex Pharmaceuticals
VRTX
$124B
$2.86M 0.62%
6,841
+1,945
+40% +$822K
CME icon
52
CME Group
CME
$95.4B
$2.81M 0.6%
13,036
+510
+4% +$107K
ZTS icon
53
Zoetis
ZTS
$33.1B
$2.77M 0.6%
16,360
+1,554
+10% +$291K
PH icon
54
Parker-Hannifin
PH
$119B
$2.73M 0.59%
4,907
+559
+13% +$284K
SPGI icon
55
S&P Global
SPGI
$125B
$2.65M 0.57%
6,230
+181
+3% +$78.5K
LMT icon
56
Lockheed Martin
LMT
$132B
$2.65M 0.57%
5,821
+513
+10% +$225K
FSK icon
57
FS KKR Capital
FSK
$3.03B
$2.6M 0.56%
136,169
+3,351
+3% +$66.3K
AMT icon
58
American Tower
AMT
$80.7B
$2.49M 0.54%
12,585
+2,600
+26% +$518K
WMB icon
59
Williams Companies
WMB
$85.7B
$2.43M 0.52%
62,322
-5,473
-8% -$194K
LIN icon
60
Linde
LIN
$234B
$2.35M 0.51%
5,063
+606
+14% +$262K
FSCO
61
FS Credit Opportunities Corp
FSCO
$997M
$2.24M 0.48%
378,515
-48,599
-11% -$279K
XOM icon
62
ExxonMobil
XOM
$653B
$2.24M 0.48%
19,249
+1,983
+11% +$207K
MSTR icon
63
Strategy Inc
MSTR
$34.7B
$2.13M 0.46%
12,500
+6,000
+92% +$547K
GOOG icon
64
Alphabet (Google) Class C
GOOG
$4.08T
$2.13M 0.46%
13,983
+3,258
+30% +$470K
IRT icon
65
Independence Realty Trust
IRT
$3.96B
$2.12M 0.46%
131,546
-37,516
-22% -$573K
RSG icon
66
Republic Services
RSG
$68.3B
$2.06M 0.44%
10,738
+34
+0.3% +$6.03K
MRK icon
67
Merck
MRK
$325B
$2.05M 0.44%
15,573
-1,034
-6% -$127K
NVO
68
Novo Nordisk
NVO
$226B
$2M 0.43%
+15,573
New +$1.85M
PG icon
69
Procter & Gamble
PG
$338B
$1.93M 0.41%
11,871
-872
-7% -$137K
IWS icon
70
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$1.9M 0.41%
15,162
+705
+5% +$83K
VOE icon
71
Vanguard Mid-Cap Value ETF
VOE
$23.9B
$1.88M 0.4%
12,030
+396
+3% +$58.1K
MTZ icon
72
MasTec
MTZ
$22.7B
$1.85M 0.4%
19,800
MO icon
73
Altria Group
MO
$126B
$1.84M 0.4%
42,251
+11,523
+38% +$478K
CVX icon
74
Chevron
CVX
$384B
$1.77M 0.38%
11,252
-937
-8% -$141K
PLD icon
75
Prologis
PLD
$135B
$1.69M 0.36%
12,959
-1,236
-9% -$161K

Similar funds

Trivium Point Advisory's Q1 2024 Portfolio in Review

As of Q1 2024, Trivium Point Advisory held 234 positions worth $465M, up 13% from $412M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trivium Point Advisory deployed $15.3M of net new capital in Q1 2024, opening 33 new positions and adding to 95 existing holdings. Its largest new stake was Novo Nordisk: 15,573 shares worth $2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Accenture, an estimated $1.55M trimmed.

  • Trivium Point Advisory's largest Q1 2024 buy was Novo Nordisk: 15,573 shares worth $2M.
  • Trivium Point Advisory added most to Walt Disney in Q1 2024, an estimated $1.17M increase.
  • Trivium Point Advisory's biggest Q1 2024 reduction was Accenture, cutting an estimated $1.55M.
  • Trivium Point Advisory fully exited Equinix in Q1 2024, selling an estimated $3.09M.
  • Trivium Point Advisory's ten largest holdings make up 28% of its $465M portfolio in Q1 2024.
  • Trivium Point Advisory opened 33 new positions and closed 15 in Q1 2024.
  • Trivium Point Advisory's portfolio value rose 13% quarter-over-quarter to $465M.

Based on Trivium Point Advisory's 13F filing for Q1 2024, filed 15 May 2024.